Systematic analysis of funding awarded for antimicrobial resistance research to institutions in the UK, 1997-2010

Article English OPEN
Head, M. G. ; Fitchett, J. R. ; Cooke, M. K. ; Wurie, F. B. ; Atun, R. ; Hayward, A. C. ; Holmes, A. ; Johnson, A. P. ; Woodford, N. (2013)
  • Publisher: Oxford University Press
  • Journal: volume 69, issue 2, pages 548-554 (issn: 0305-7453, eissn: 1460-2091)
  • Related identifiers: pmc: PMC3886928, doi: 10.1093/jac/dkt349., doi: 10.1093/jac/dkt349
  • Subject: antifungal | antiviral | antiparasitic | Original Research | Antibiotics, Antifungal, Antiparasitic, Antiviral | antibiotics
    mesheuropmc: health care economics and organizations

Objectives: To assess the level of research funding awarded to UK institutions specifically for antimicrobial resistance-related research and how closely the topics funded relate to the clinical and public health burden of resistance.<br/><br/>Methods: Databases and web... View more
  • References (33)
    33 references, page 1 of 4

    1 Atun R, Weil DEC, Eang MT et al. Health-system strengthening and tuberculosis control. Lancet 2010; 375: 2169 - 78.

    2 Zumla A, Abubakar I, Raviglione M et al. Drug-resistant tuberculosis-current dilemmas, unanswered questions, challenges, and priority needs. J Infect Dis 2012; 205 Suppl 2: S228 - 40.

    3 Coker RJ, Atun RA, McKee M. Health-care system frailties and public health control of communicable disease on the European Union's new eastern border. Lancet 2004; 363: 1389- 92.

    4 Van der Bij AK, Pitout JDD. The role of international travel in the worldwide spread of multiresistant Enterobacteriaceae. J Antimicrob Chemother 2012; 67: 2090 - 100.

    5 Sengaloundeth S, Green MD, Ferna´ ndez FM et al. A stratified random survey of the proportion of poor quality oral artesunate sold at medicine outlets in the Lao PDR-implications for therapeutic failure and drug resistance. Malar J 2009; 8: 172.

    6 Davey PG, Marwick C. Appropriate vs. inappropriate antimicrobial therapy. Clin Microbiol Infect 2008; 14 Suppl 3: 15 - 21.

    7 Wise R. The urgent need for new antibacterial agents. J Antimicrob Chemother 2011; 66: 1939- 40.

    8 Livermore DM. Fourteen years in resistance. Int J Antimicrob Agents 2012; 39: 283 - 94.

    9 Bell JM, Turnidge JD, Gales AC et al. Prevalence of extended spectrum b-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998 - 99). Diagn Microbiol Infect Dis 2002; 42: 193- 8.

    10 Chaudhuri BN, Rodrigues C, Balaji V et al. Incidence of ESBL producers amongst Gram-negative bacilli isolated from intra-abdominal infections across India (based on SMART study, 2007 data). J Assoc Physicians India 2011; 59: 287 - 92.

  • Similar Research Results (2)
  • Metrics
    0
    views in OpenAIRE
    0
    views in local repository
    17
    downloads in local repository

    The information is available from the following content providers:

    From Number Of Views Number Of Downloads
    LSHTM Research Online - IRUS-UK 0 2
    e-Prints Soton - IRUS-UK 0 7
    UCL Discovery - IRUS-UK 0 8
Share - Bookmark